Roundtable Participants
Frederick Abbott, Edward Ball Eminent Scholar Professor of Law, Florida State University College of Law, Tallahassee (Organizer)
Tahir Amin, Co-Founder, Initiative for Medicines, Access & Knowledge, New Delhi
Wilbert Bannenberg, Public Health Consultant, formerly WHO Pharmaceutical Technical Adviser to the South African Department of Health, The Netherlands
Jorge A.Z. Bermudez, Unit Chief, Essential Medicines, Vaccines and Health Technologies, Pan American Health Organization (PAHO), Washington, D.C.
Carlos Correa, Professor and Director, Centre for Interdisciplinary Studies on Industrial Property and Economics Law, University of Buenos Aires, Argentina
Timothy Cross, Director, Nuclear Magnetic Resonance Program, National High Magnetic Field Laboratory, Florida State University, Tallahassee
Graham Dukes, Professor of Drug Policy Studies, University of Oslo, Norway
Paulo Etcheverry, representing ALIFAR (also General Manager, Laboratorios Rowe, Dominican Republic, and President, INFADOMI, Dominican Republic), Santa Domingo
Carsten Fink, Senior Economist, Trade Team, World Bank Institute, Geneva
Joseph Fortunak, Associate Professor, Chemistry and Pharmaceutical Sciences, Howard University, formerly Director and Head, Global Process R&D, Abbott Laboratories, Washington, D.C.
John Fraser, President, Association of University Technology Managers; Director, Office of IP Development and Commercialization, Florida State University, Tallahassee
Marta Gabrieloni, Argentina Ministry of Foreign Affairs, Secretary of Commerce, Buenos Aires
Elisabet Helsing, Norwegian Board of Health, former Head of WHO Nutrition Program, Oslo
Ellen 't Hoen, Director for Policy Advocacy, Medecins Sans Frontieres (MSF), Campaign for Access to Essential Medicines, Paris
Maria Fernanda Hurtado, Ministry of Trade, Colombia
Marķa Fabiana Jorge, President, MFJ International, LLC, Washington, D.C.
Lorelei Ritchie de Larena, Assistant Professor, Florida State University College of Law, formerly Intellectual Property Manager, UCLA
David Lee, Deputy Director for Technical Strategy and Quality for the MSH Center for Pharmaceutical Management, Arlington, Virginia
James P. Love, Director, Consumer Project on Technology, Washington, D.C.Thomas Mays, Counsel for Intellectual Property, U.S. Federal Trade Commission, Washington, D.C.
Priti Radhakrishnan, Co-Founder, Initiative for Medicines, Access & Knowledge, New Delhi
Jerome Reichman, Bunyan S. Womble Professor of Law, Duke Law School, Durham
Pedro Roffe, Senior Fellow ICTSD, Project on Intellectual Property and Sustainable Development, Geneva
Mark Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health (NIH), Rockville, Maryland
Giorgio Roscigno, Chief Executive Officer, FIND (Foundation for Innovative New Diagnostics), Geneva
Dilip Shah, Secretary-General, Indian Pharmaceutical Alliance (IPA), Mumbai
Michael Steffen, Co-Executive Director, Universities Allied for Essential Medicines, New Haven
Robynn Sturm, Co-Executive Director, Universities Allied for Essential Medicines, New Haven
Antony Taubman, Acting Director and Head, Global IP Issues Division, World Intellectual Property Organization (WIPO), Geneva
Yolanda Tayler, Lead Specialist Procurement/Health, The World Bank, Washington, D.C.
Gina Vea, Program Officer, Intellectual Property and Technology, ICTSD, Geneva
Howard Zucker, Assistant Director-General, Health Technology and Pharmaceuticals (HTP), World Health Organization, Geneva
